Search Results 1411-1420 of 16325 for alt

  1. A Study to Evaluate the Effects of N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease) - Mayo Clinic

    Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >5x upper limit of normal (ULN);; Total bilirubin >1.5x ULN, unless Gilbert's syndrome is ...

  2. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

    * Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 3 × institutional ULN (within 28 days prior to registration) * Lactate dehydrogenase ...

  3. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

    Participation eligibility · Hepatic: total bilirubin ≤1.5 times upper limit of normal (ULN); alanine transaminase (ALT) and aspartate transaminase (AST) ≤1.5 ...

  4. A Study to Evaluate Aspirin for Treating Multiple Sclerosis-related Fatigue - Mayo Clinic

    Aspartate aminotransferase (AST/SGOT) or alanine aminotransferase (ALT/SGPT) level greater than 2.5 times the upper limit of normal. Participating Mayo ...

  5. Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3 x ULN. Ability to swallow oral medication. Provide written informed consent ...

  6. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

    AST (SGOT) and ALT (SGPT): ≤2.5xULN OR ≤5xULN for subjects with liver metastases. Coagulation: INR or PT: ≤1.5xULN unless subject is receiving ...

  7. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    Patient must have adequate liver function defined as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x institutional upper level of ...

  8. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

    ALT or AST > 5 × upper limit of normal (ULN) 7. Abnormal liver function as defined by central laboratory evaluation: Albumin < LLN INR ≥ 1.3 (unless ...

  9. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma - Mayo Clinic

    ... [ALT]) ≤ 110 U/L. For the purpose of this study, the ULN for SGPT is 45 U/L. Serum albumin ≥ 2 g/dL; No evidence of dyspnea at rest and a pulse oximetry > 94 ...

  10. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

    Aspartate transaminase (AST) AND alanine transaminase (ALT) ≤ 2.5 x ULN;; Creatinine ≤ 1.0 x ULN OR measured or calculated creatinine clearance (per ...